Invasive honeysuckles attract pollinators, but that's where the benefits end. To save your garden and nearby natural areas, ...

Butterfly Bush is one of those shrubs that gets the best of a lot of us. We never can truly anticipate just how huge they can get over the course of a season! So in this video I clearly demonstrate ...

We may receive a commission on purchases made from links. If you want your yard to feel less like a fishbowl and more like your own secluded sanctuary without waiting a decade or spending a fortune on ...

Recurrences of low-, intermediate-, or high-/very high-risk tumors were again low, intermediate, or high risk in 74%, 62%, and 44% of cases, respectively. Recurrent non-muscle invasive bladder cancer ...

Apple @ Work is exclusively brought to you by Mosyle, the only Apple Unified Platform. Mosyle is the only solution that integrates in a single professional grade platform all the solutions necessary ...

Indiana has rich biodiversity with thousands of species in unique habitats, but the ornamental plant trade, globalization and development have introduced new threats to these ecosystems. IndyStar is ...

Synaptrix Labs, a startup building a wearable brain-computer interface platform recently secured seed funding from Mark Cuban to accelerate commercial traction. Neuralis is the company’s wearable BCI ...

NMIBC treatment varies by tumor stage, grade, and prior therapies, with high-risk cases often requiring radical cystectomy. Bladder-preserving approaches include intravesical therapies like BCG, ...

Butterfly bushes are considered invasive plants in many areas of the United States. Native plants like asters and zinnias are equally attractive to butterflies and other pollinators. If planting a ...

One of several boxwoods I planted in a group this spring is turning brown and looking bad. The rest are doing fine. What could be the problem and what can I do to save it? There are several things ...

Imagine correcting your vision in under a minute – no lasers, blades or pain. Scientists have developed a novel, non-invasive technique that reshapes the cornea using only a mild electric current and ...

Zusduri demonstrated a 72.2% 24-month response durability in LG-IR-NMIBC patients, leading to FDA approval as a non-surgical treatment option. The ENVISION trial enrolled 240 patients, focusing on ...